VITALE, Mario
 Distribuzione geografica
Continente #
NA - Nord America 10.686
AS - Asia 9.596
EU - Europa 3.616
SA - Sud America 902
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 24.893
Nazione #
US - Stati Uniti d'America 10.566
HK - Hong Kong 6.185
CN - Cina 1.111
UA - Ucraina 1.087
SG - Singapore 952
IT - Italia 775
BR - Brasile 764
VN - Vietnam 576
DE - Germania 498
RU - Federazione Russa 338
TR - Turchia 318
FI - Finlandia 282
IE - Irlanda 232
KR - Corea 228
SE - Svezia 170
IN - India 82
GB - Regno Unito 71
CA - Canada 69
AR - Argentina 47
MX - Messico 30
FR - Francia 29
ZA - Sudafrica 28
ID - Indonesia 25
EC - Ecuador 24
BD - Bangladesh 22
PY - Paraguay 21
PL - Polonia 20
AT - Austria 19
JP - Giappone 19
NL - Olanda 19
IQ - Iraq 17
CO - Colombia 14
CZ - Repubblica Ceca 13
ES - Italia 13
IL - Israele 13
UY - Uruguay 11
EU - Europa 10
MA - Marocco 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
KE - Kenya 7
LT - Lituania 7
VE - Venezuela 7
AU - Australia 6
EG - Egitto 6
RO - Romania 6
UZ - Uzbekistan 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
PE - Perù 4
PT - Portogallo 4
RS - Serbia 4
BE - Belgio 3
BG - Bulgaria 3
CR - Costa Rica 3
JM - Giamaica 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PK - Pakistan 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GE - Georgia 2
HR - Croazia 2
JO - Giordania 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
PF - Polinesia Francese 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 24.884
Città #
Hong Kong 6.182
Ann Arbor 2.736
Jacksonville 1.278
Wilmington 975
Chandler 912
Princeton 833
Dallas 620
Woodbridge 363
Dong Ket 359
Ashburn 349
Singapore 322
Izmir 300
Nanjing 254
Dublin 230
Andover 225
Boardman 183
Salerno 177
Beijing 174
Munich 171
Houston 167
Pellezzano 161
Moscow 128
Shenyang 85
Changsha 82
Ho Chi Minh City 81
Fairfield 78
Los Angeles 77
Düsseldorf 76
Nanchang 70
Hebei 67
São Paulo 66
Jiaxing 60
Norwalk 51
Naples 48
Hanoi 45
Dearborn 42
New York 40
Pune 40
Washington 40
Ottawa 38
Helsinki 37
Seattle 34
Tianjin 30
Rio de Janeiro 29
Council Bluffs 28
Chicago 26
Mestre 26
Brooklyn 25
Rome 23
Turku 23
Johannesburg 22
Santa Clara 22
Cambridge 21
Nuremberg 20
Boston 19
Brasília 19
Tokyo 19
Warsaw 19
Belo Horizonte 18
Curitiba 18
Phoenix 18
London 17
Redwood City 16
Jinan 15
San Francisco 14
Columbus 13
Montreal 13
Salvador 13
San Diego 13
Stockholm 13
Da Nang 12
Asunción 11
Guangzhou 11
Montevideo 11
Napoli 11
Orem 11
Thái Bình 11
Atlanta 10
Brno 10
Haiphong 10
Mumbai 10
Porto Alegre 10
The Dalles 10
Vienna 10
Baghdad 9
Manaus 9
Mexico City 9
Milan 9
Quito 9
Amsterdam 8
Ankara 8
Poplar 8
Ribeirão Preto 8
Denver 7
Falls Church 7
Guarulhos 7
Manchester 7
Ninh Bình 7
Toronto 7
Campinas 6
Totale 19.081
Nome #
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients 785
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 542
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). 540
Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. 477
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 466
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 442
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 406
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 363
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 325
Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis 309
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 301
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 298
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 287
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 238
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 198
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 197
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 193
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 168
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 161
Higher integrin alpha 3 beta1 expression in papillary thyroid cancer is associated with worst outcome 159
Migration of surgical clips through a right lobectomy stump mimicking an asthmatic syndrome 158
GH provocative tests stimulate the growth in children with idiopathic short stature 148
LA CHINASI CALCIO-CALMODULINA DIPENDENTE II (CAMKII) E’ COSTITUTIVAMENTE ATTIVATA NEI CARCINOMI PAPILLIFERI DELLA TIROIDE 143
Apoptosis in thyroid cells induced by denied adhesion to extracellular-matrix (anoikis) is p53-dependent and associates with expression of hypophosphorylated bad. 141
Anandamide inhibits adhesion and migration of breast cancer cells. 140
BRAF mutation analysis in thyroid nodules with indeterminate cytology: Our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency 135
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. 132
Detection of RAS mutation by pyrosequencing in thyroid cytology samples 130
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 129
An unusual case of primary choriocarcinoma of the lung 128
Surgical management of cervico-mediastinal goiters: Our experience and review of the literature 127
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 122
Adhesion molecules expression in human follicular thyroid cells of normal and diseased glands. 119
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 118
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 118
Hypocalcaemia after total thyroidectomy: could intact parathyroid hormone be a predictive factor for transient postoperative hypocalcemia? 117
Approccio clinico al paziente con gozzo. 116
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 116
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review 115
Behavior of SaOS-2 cells cultured on different titanium surfaces. 115
Hypocalcaemia after total thyroidectomy: Could intact parathyroid hormone be a predictive factor for transient postoperative hypocalcemia? 115
Cytological diagnosis of lymph nodes by instrumental guide: Ultrasonography and CT (La diagnosi citologica dei linfonodi con guida strumentale: Ecografia e TC) 112
Thyroid adiponcosis: more than an hypothesis 110
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome. 110
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 109
Nodular goiter with amyloid deposition in an elderly patient: Fine-needle cytology diagnosis and review of the literature 108
Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients 107
Fine needle cytology pre-surgical differentiation of parathyroid neoplasms: Is it reliable? 107
RET rearrangements in benign thyroid nodules correlate with a greater volume increase 106
Tiroidite subacuta in un paziente in trattamento immunosoppressivo 105
Cytological diagnosis of the thyroidal nodule: A review 105
Amiodarone induces apoptosis in thyroid and non thyroid cells through a iodine-independent mechanism. 104
High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. 103
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. 103
ANALISI DELLA MUTAZIONE V599E DI BRAF NEI TUMORI TIROIDEI MEDIANTE MUTANT ALLELE SPECIFIC AMPLIFICATION (MASA) 103
L’adesione dei fibroblasti del legamento paradontale alla matrice extracellulare è mediata dalle integrine della famiglia beta 1. 102
Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. 100
Pituitary dysfunction and its association with quality of life in traumatic brain injury 100
Fibronectin is required to prevent thyroid cell apoptosis through an integrin-mediated adhesion mechanism. 99
[Update on diabetic foot infections.] 99
Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol. 98
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 98
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines. 97
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay. 95
The role of a multidisciplinary approach in the choice of the best surgery approach in a super-super-obesity case. 95
Prevalence of Dio2 T92A polymorphism and its association with thyroid autoimmunity. 93
Interactions of promonocytic U937 cells with proteins of the extracellular matrix. 93
Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and rewiew of the literature 93
Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. 92
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 91
Post-thyroidectomy complications. The role ofthe device: Bipolar vs ultrasonic device. Collection of data from 1,846 consecutive patients undergoing thyroidectomy 91
Regulation of the expression of the low-affinity IgE receptor (FceRII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. 90
Autoimmunità e patologia testicolare. 90
Fine needle cytology and flow cytometry in hashimoto thyroiditis and primary thyroid lymphoma 90
Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients 89
Combined analysis of galectin-3 and BRAF(V600B) improves the accuracy of fine-needle aspiration biopsy with indeterminate cytology 89
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 87
BRAFmutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 87
Collagene e fibronectina sono fattori di crescita per le cellule tiroidee. 86
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 86
The evolving field of kinase inhibitors in thyroid cancer 86
Thyroid tumors lose the polarized expression of the VLA family of integrins. 85
Efficacia e sicurezza dell'inibitore chinasico Sorafenib nel trattamento del carcinoma differenziato tiroideo aggressivo 85
Are RET/PTC rearrangements in benign thyroid nodules of biological significance? 84
Integrin expression in human thyroid cell lines and effect of N-ras overexpression. 84
Nelle cellule follicolari di tiroide in coltura la proliferazione si associa ad elevata espressione di alcune integrine. 84
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 84
Valore clinico degli oncogeni RET/PTC e BRafV600E nella diagnosi dei noduli tiroidei 84
LA RICERCA DEGLI ONCOGENI RET/PTC, TRK E BRAFV600E NEGLI AGOASPIRATI INCONCLUSIVI MIGLIORA LA DIAGNOSI CITOLOGICA E MODIFICA LA SCELTA TERAPEUTICA 84
Retinoic acid alone and in combined treatment with proinflammatory cytokines induces ICAM-1 up-regulation in human thyroid cell lines. 84
Disturbance of humoral immune system and female reproduction. 83
Modulazione di ICAM-1 in membrana e rilascio di forma solubile indotti da agenti stimolanti in linee umane di carcinoma tiroideo. 83
Sorafenib stops disease progression in the majority of patients with advanced differentiated thyroid cancer refractory to radioactive iodine. 82
Collagene e fibronectina stimolano la sintesi di DNA e la proliferazione delle cellule tiroidee umane. 82
LA CHINASI CALCIO-CALMODULINA DIPENDENTE TIPO II E’ NECESSARIA PER LA PROLIFERAZIONE DELLE CELLULE DI CARCINOMA PAPILLARE TIROIDEO 81
Loss of polarity and de novo expression of the beta 1 family of integrins in thyroid tumors. 80
ROLE OF THE Ca2+-CALMODULIN DEPENDENT KINASE II (CAMKII) IN THE PROLIFERATION OF PAPILLARY THYROID CARCINOMAS 80
Different effect of serum, collagen and fibronectin on normal and neoplastic thyroid cell growth. 80
L’acido retinoico da solo e in associazione con citochine proinfiammatorie induce una aumentata espressione di ICAM-1 in linee umane di tiroide. 80
Collagene e fibronectina sono fattori di crescita in cellule tiroidee normali e tumorali. 80
Totale 15.014
Categoria #
all - tutte 73.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.414 0 0 0 0 228 58 235 3 230 6 247 407
2021/20221.456 9 2 7 9 21 15 16 70 235 216 188 668
2022/20232.174 270 103 49 213 318 454 11 239 341 9 117 50
2023/2024926 89 150 86 50 75 168 14 53 5 39 55 142
2024/20252.412 105 47 43 95 111 274 450 343 412 74 231 227
2025/20268.700 1.014 3.814 2.994 778 100 0 0 0 0 0 0 0
Totale 25.260